Not Just an Inhibitor: A Role for p21 Beyond the Cell Cycle - "The Truth Is Rarely Pure and Never Simple"

Journal of the American Society of Nephrology

Volumn 15, Issue 3, 2004, Pages 825-826

  Griffin, Siân V ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21;

CELL CYCLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EDITORIAL; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MESANGIUM; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 1542288783     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000117896.79378.43     Document Type: Editorial

References (24)

1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890, 2003
2. Harvey J: Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes. Curr Opin Nephrol Hypertens 12: 317-323, 2003
3. waf1/cip1 decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1. J Am Soc Nephrol 15: 575-584, 2004
4. Sherr CJ, Roberts JM: CDK inhibitors: Positive and negative regulators of G1 phase progression. Gen Dev 13: 1501-1512, 1999
5. Griffin SV, Pichler RH, Wada T, Vaughan M, Durvasula R, Shankland SJ: The role of cell cycle proteins in glomerular disease. Semin Nephrol 23: 569-582, 2003
6. Kuan C-J, Al-Douahji M, Shankland SJ: The cyclin kinase inhibitor p21Waf1,Cip1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy. J Am Soc Nephrol 9: 986-993, 1998
7. Al-Douahji M, Brugarolas J, Brown PAJ, Stehman-Breen CO, Alpers CE, Shankland SJ: The cyclin kinase inhibitor p21Waf1/Cip1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int 56: 1691-1699, 1999
8. Wolf G, Schroeder R, Thaiss F, Ziyadeh FN, Helmchen U, Stahl RAK: Glomerular expression of p27Kip1 in diabetic db/db mouse: Role of hyperglycaemia. Kidney Int 53: 869-879, 1998
9. Awazu M, Omori S, Ishikura K, Hida M, Fujita H: The lack of cyclin kinase p27Kip1 ameliorates progression of diabetic nephropathy. J Am Soc Nephrol 14: 699-708, 2003
10. Wolf G, Schroeder R, Ziyadeh FN, Thaiss F, Zahner G, Stahl RAK: High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells. Am J Physiol 42: F348-F356, 1997
11. Wolf G: Molecular mechanisms of renal hypertrophy: Role of p27Kip1. Kidney Int 56: 1262-1265, 1999
12. Wolf G, Schroeder R, Zahner G, Stahl RAK, Shankland SJ: High glucose-induced hypertrophy of mesangial cells requires p27Kip1, an inhibitor of cyclin dependent kinases. Am J Path 158: 1091-1100, 2001
13. Wolf G, Hannken T, Zahner G, Shankland SJ, Stahl RAK: p44/p42 MAP kinase directly phosphorylates the CDK inhibitor p27Kip1: Role in hypertrophy [Abstract]. J Am Soc Nephrol 12:623A, 2001
14. Toyoshima H, Hunter T: p27, a novel inhibitor of GI cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994
15. Monkawa T, Hiromura K, Wolf G, Shankland SJ: The hypertrophic effect of TGF beta is reduced in the absence of the cyclin dependent kinase inhibitors p21 and p27. J Am Soc Nephrol 13: 1172-1178, 2002
16. LaBaer J, Garrett M, Stevenson L, Slingerland J, Sandhu C, Chou H, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Gen Dev 11: 847-862, 1997
17. Alt JR, Gladden AB, Diehl JA: p21(Cip1) promotes cyclin DI nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 277: 8517-8523, 2002
18. Zhou BP, Liao Y, Xia W, Spohn B, Lee M-H, Hung M-C: Cytoplasmic localization of p21Cip1/Waf1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3:245-251, 2001
19. Dong Y, Chi SL, Borowsky AD, Fan Y, Weiss RH: Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells. Cell Signal 16: 263-269, 2004
20. Coqueret O: New roles for p21 and p27 cell cycle inhibitors: A function for each cell compartment? Trends Cell Biol 13: 65-70, 2003
21. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumoro K, Mizutani S: Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/Waf1) in monocytic differentiation. EMBO J 18: 1223-1234, 1999
22. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M: Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17: 931-939, 1998
23. Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tokyama M: Cytoplasmic p21(Cip1/WAF1) regulates neurite remodelling by inhibiting Rho-kinase activity. J Cell Biol 158: 321-329, 2002
24. Lee S, Helfman DM: Cytoplasmic p21Cip1 is involved in Ras-related inhibition of the ROCK/LIMK/Cofilin pathway. J Biol Chem 279: 1885-1891, 2004